×
InspireMD Net Profit Margin 2013-2024 | NSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
InspireMD net profit margin from 2013 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
InspireMD Net Profit Margin 2013-2024 | NSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
InspireMD net profit margin from 2013 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$211B
Intuitive Surgical (ISRG)
$191.1B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.8B
Edwards Lifesciences (EW)
$39.1B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$27.3B
Waters (WAT)
$22.8B
SONOVA HOLDING (SONVY)
$22.1B
STERIS (STE)
$21.6B
Hologic (HOLX)
$18.3B
Sysmex ADR (SSMXY)
$12.9B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Globus Medical (GMED)
$11B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.7B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.2B
Integer Holdings (ITGR)
$4.6B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.3B